Technology
The AHA Center for Health Innovation released a new report to guide hospital and health system executives on using artificial intelligence and AI-powered technologies to transform their organizations’ operations.
A guide published Jan. 13 by the Cybersecurity and Infrastructure Security Agency, National Security Agency, FBI, Environmental Protection Agency, Transportation Security Administration and international agencies provides considerations for organizations to select and secure operational technology…
The Department of Health and Human Services Dec. 16 published a final rule implementing certain provisions related to information blocking exceptions. The rule revises defined terms related to protecting access to care for purposes of the information blocking regulations.
The Department of Health and Human Services Dec. 11 published a final rule implementing provisions related to the Trusted Exchange Framework and Common Agreement.
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex Pharmaceuticals (manufacturer of Casgevy) will participate in its Cell and Gene Therapy Access Model.
30 years from now, it's projected that nearly one quarter of America's population will be age 65 or older.
Leadership Dialogue Series: The Future Is Here — Artificial Intelligence and Its Role in Health Care
In this conversation, Joanne M. Conroy, M.D. (2024 chair AHA) and Amy Perry (CEO Banner Health), discuss using technology to transform patient care.
AHA President and CEO Rick Pollack was recently a guest on Pinkston's "To the Point" podcast to discuss the future of U.S. health care, touching on a range of topics including unique challenges facing urban and rural hospitals, artificial intelligence and cybersecurity, and more.
The AHA Oct. 4 commented on the Department of Health and Human Services' Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability (HTI-2) proposed rule. AHA expressed support for HHS' efforts to advance interoperability, improve…
For years, the first-line treatment for atrial fibrillation, or A-fib, has been blood thinners. A-fib, which is a cardiac rhythm abnormality, can lead to other health complications, including strokes — it’s estimated that 90% of all strokes happen in patients who have A-fib.